Metraipolis › archive › dc_7f0185155000
Trends in Glucagon-Like Peptide-1 Agonist Use and BMI Among Obese Adults With Type 2 Diabetes: Analysis of the 2010-2015 National Ambulatory Medical Care… — Europe PMC PMID:40951131
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40951131
- DOI
- 10.7759/cureus.90054
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T15:40:41.913Z
- SHA-256 of the archived text
1b2284fd9766bdcbec9d27ed4670dc20f4884577fb51199164b46a28d04ff8ab- Stable URL of this page
https://metraipolis.com/documento/dc_7f0185155000
How to cite
Trends in Glucagon-Like Peptide-1 Agonist Use and BMI Among Obese Adults With Type 2 Diabetes: Analysis of the 2010-2015 National Ambulatory Medical Care… — Europe PMC PMID:40951131 — Europe PMC (en), https://europepmc.org/article/MED/40951131 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7f0185155000 (Metraipolis archive dc_7f0185155000, sha256 1b2284fd9766bdcbec9d27ed4670dc20f4884577fb51199164b46a28d04ff8ab)
BibTeX
@misc{dc7f0185155000,
title = {Trends in Glucagon-Like Peptide-1 Agonist Use and BMI Among Obese Adults With Type 2 Diabetes: Analysis of the 2010-2015 National Ambulatory Medical Care… — Europe PMC PMID:40951131},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40951131},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7f0185155000; sha256 1b2284fd9766bdcbec9d27ed4670dc20f4884577fb51199164b46a28d04ff8ab},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40951131. Agents can read the archived copy with the MCP tool read_document.